CDKN2A and cancer: p16INK4a induces permanent growth arrest termed “cellular senescence.” Association studies have suggested that altered regulation of p16INK4a expression may result in human age-associated phenotypes such as type 2 diabetes6, atherosclerotic disease7, cancer susceptibility8, 9, 10, 11, and longevity12, 13, 14.